- Scientists have engineered a potential new treatment for endometriosis by adapting niclosamide, an anti-parasitic drug historically used to treat tapeworms.
- Researchers attached the drug to microscopic carriers targeted with folic acid to focus specifically on the immune cells that fuel endometrial lesions.
- In mouse trials published in Advanced Healthcare Materials, the targeted treatment shrank lesions, reduced pain sensitivity, and lowered disease-causing cells.
- If successfully replicated in human trials, the discovery could offer a breakthrough non-hormonal and non-surgical option delivered via periodic injections.
- The potential treatment brings hope to an estimated 190 million people worldwide who suffer from the chronic condition and face limited current options.
IN FULL